Dectin-1/CLEC7A Products

Description

Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Bioinformatics

Product By Gene ID

64581

Alternate Names

Beta-glucan receptor BGR CD369 CLEC7A CLECSF12 CLECSF12DC-associated C-type lectin 1 C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamilymember 12 C-type lectin domain family 7 member A C-type lectin domain family 7, member A C-type lectin superfamily member 12 Dectin1 Dectin-1 DECTIN1CANDF4 Dendritic cell-associated C-type lectin 1 dendritic cell-associated C-type lectin-1 hDectin-1 lectin-like receptor 1

Research Areas for Dectin-1/CLEC7A

Find related products by research area and learn more about each of the different research areas below.

Signal Transduction

Related Dectin-1/CLEC7A Blog Posts

Check out the latest blog posts on Dectin-1/CLEC7A.

Read more.

Read more Dectin-1/CLEC7A related blogs.